IRIS
BENEDETTI, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.451
NA - Nord America 4.197
AS - Asia 2.296
SA - Sud America 423
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 31
OC - Oceania 1
Totale 12.571
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.082
RU - Federazione Russa 3.601
SG - Singapore 813
IT - Italia 748
CN - Cina 490
IE - Irlanda 426
BR - Brasile 344
HK - Hong Kong 308
VN - Vietnam 306
DE - Germania 131
KR - Corea 128
GB - Regno Unito 121
UA - Ucraina 93
IN - India 87
FI - Finlandia 78
CA - Canada 42
FR - Francia 41
AR - Argentina 39
NL - Olanda 37
JP - Giappone 31
SE - Svezia 31
TR - Turchia 29
GR - Grecia 26
MX - Messico 26
AT - Austria 19
PK - Pakistan 19
ES - Italia 18
EC - Ecuador 17
DK - Danimarca 14
HU - Ungheria 12
BE - Belgio 11
CR - Costa Rica 11
IQ - Iraq 11
UZ - Uzbekistan 11
BD - Bangladesh 10
PL - Polonia 10
ID - Indonesia 9
MA - Marocco 8
GT - Guatemala 7
PT - Portogallo 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
CO - Colombia 5
IL - Israele 5
JM - Giamaica 5
SV - El Salvador 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
KE - Kenya 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
ZA - Sudafrica 4
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
HN - Honduras 3
LK - Sri Lanka 3
NP - Nepal 3
PH - Filippine 3
PR - Porto Rico 3
BS - Bahamas 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
IM - Isola di Man 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AU - Australia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
HR - Croazia 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
Totale 12.398
Salva come PNG Salva come JPEG
Città #
Moscow 1.294
Chicago 561
Wilmington 433
Singapore 427
Dublin 424
San Jose 413
Falls Church 334
Hong Kong 299
Santa Clara 298
Ashburn 257
Chandler 193
Council Bluffs 162
Jacksonville 135
Naples 131
Seoul 126
Beijing 107
Hefei 93
Ho Chi Minh City 91
Hanoi 64
New York 63
Milan 60
Bengaluru 54
Princeton 51
Caserta 48
Dallas 47
Los Angeles 44
Helsinki 39
Munich 38
Roxbury 37
Boardman 36
The Dalles 34
Orem 30
São Paulo 30
Medford 29
Dong Ket 26
Aversa 25
Rome 25
Memphis 20
Haiphong 18
Amsterdam 16
Ann Arbor 16
Houston 16
Cambridge 15
Chennai 14
Florence 14
Miano 14
Napoli 14
Phoenix 14
Stuttgart 14
Vienna 14
Bremen 13
Brooklyn 13
Nuremberg 13
Buenos Aires 12
Da Nang 12
Hillsboro 12
Rio de Janeiro 12
Copenhagen 11
Mexico City 11
Montreal 11
Tashkent 11
Belo Horizonte 10
Des Moines 10
London 10
North Bergen 10
San Mateo 10
Warsaw 10
Boston 9
Hải Dương 9
Newark 9
Piscataway 9
San José 9
Seattle 9
Afragola 8
Atlanta 8
Curitiba 8
Mountain View 8
Quito 8
San Francisco 8
San Giuseppe Vesuviano 8
Turku 8
Cicciano 7
Denver 7
Frankfurt am Main 7
Lappeenranta 7
Salvador 7
Woodbridge 7
Brussels 6
Columbus 6
Groningen 6
Guangzhou 6
Jakarta 6
Mumbai 6
Porto Alegre 6
Shanghai 6
Stockholm 6
Thái Bình 6
Tianjin 6
Tokyo 6
Toronto 6
Totale 7.186
Salva come PNG Salva come JPEG
Nome #
Epigenetic mechanisms underlying prostate cancer radioresistance 1.440
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 230
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma 227
HIF3A inhibition triggers browning of white adipocytes via metabolic rewiring. 205
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 191
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 188
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 183
Deregulation of new cell death mechanisms in Leukemia 182
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 182
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 181
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 174
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 172
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients:a meta-analysis of randomized clinical trials 171
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 170
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics 168
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 165
Breast Cancer Vaccines: New Insights 161
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification 159
Epigenetic-based therapy: From single- to multi-target approaches 158
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer 158
Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives 157
Involvement of regulated cell deaths in aging and age-related pathologies 157
HAT1: Landscape of Biological Function and Role in Cancer 157
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 156
The role of SAHA in boron uptake: harnessing epigenetic regulation of LAT1 for optimized BNCT 153
Modulation of Autophagy and Apoptosis in Leukemia 153
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 149
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 149
EPIGENETIC MODULATION OF LAT1 EXPRESSION TO ENHANCE OSTEOSARCOMA SENSITIVITY TO BORON NEUTRON CAPTURE THERAPY (BNCT) 148
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 148
HDAC6 inhibition extinguishes autophagy in cancer: Recent insights 148
From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment 146
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 146
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 144
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 143
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer 142
Role of Ferroptosis in AML Pathophysiology and Therapeutic Strategies 142
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity 142
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 142
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma 136
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 136
EPIGENETIC-BASED DRUGS IN STEM CELL DIFFERENTIATION 136
Design and Synthesis of New Oligopeptidic Parvulin Inhibitors 136
Unravelling the impact of the chromobox proteins in human cancers 133
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research 131
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 131
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy 131
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 130
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 129
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells. 128
DNA Mutations via Chern-Simons Currents 128
I BET on anti-FGFR to fight cancer resistance 127
Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor 126
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90 125
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome 125
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 124
Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells. 124
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 123
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 122
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 120
In-Depth Exploration of Radiation-Induced Cell Death Mechanisms in Tumor 119
Current Preclinical Applications of Pharmaco-Epigenetics in Cardiovascular Diseases 119
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game? 118
Harnessing normalcy: The potential of healthy tissuefor patient outcomes 118
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 118
Is it time to revise the fighting strategy toward type 2 diabetes? Sex and pollution as new risk factors 117
“Aging and epigenetic implications in radiotherapy: The promise of BNCT” 115
Trials with 'epigenetic' drugs: An update. 114
Targeting HDACs in diseases: where are we? 112
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 112
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 111
New Anacardic Acid-Inspired Benzamides: Histone Lysine Acetyltransferase Activators 108
The innovative potential of selenium-containing agents for fighting cancer and viral infections 103
Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs) 101
Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation. 99
Structure-Activity Relationships on Cynnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase 99
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 87
Phase separation rewires chromatin in breast cancer 84
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma 78
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 65
Interplay between DNA and RNA methylation shapes cancer cell plasticity 36
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells 28
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab 22
Totale 12.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022699 0 0 0 95 163 42 40 31 27 81 62 158
2022/20231.271 143 110 339 57 68 49 5 41 415 10 13 21
2023/2024442 30 13 16 21 88 65 16 34 11 31 36 81
2024/20251.465 15 39 46 70 206 158 253 133 165 118 128 134
2025/20266.518 306 355 358 323 515 3.388 289 339 245 199 156 45
2026/20271.082 63 169 388 462 0 0 0 0 0 0 0 0
Totale 12.571